Source link : https://www.newshealth.biz/health-news/fda-updates-glp-1-label-with-pulmonary-aspiration-warning/
On November 5, the US Food and Drug Administration (FDA) updated the labels for all glucagon-like peptide 1 receptor agonists (GLP-1 RA) with a warning about pulmonary aspiration during general anesthesia or deep sedation. The affected drugs are semaglutide (Ozempic, Rybelsus, Wegovy); liraglutide (Saxenda, Victoza); and the dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 tirzepatide (Mounjaro, Zepbound). […]
Author : News Health
Publish date : 2024-11-06 07:07:44
Copyright for syndicated content belongs to the linked Source.